Arecor Therapeutics
Completion of AVA6000 sixth dose escalation and clinical updateArecor Therapeutics
Positive data from first stage of SCIB1 Phase II SCOPE trial in advanced melanomaArecor Therapeutics
Presentation of results from the Phase IIIb trial of savolitinib at WCLC 2023Arecor Therapeutics
Completion of enrollment in tazemetostat China bridging study in r/r FL